Company Filing History:
Years Active: 2011
Title: Frank Kuhnert: Innovator in Angiogenesis Modulation
Introduction
Frank Kuhnert is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis modulation. His work focuses on developing methods that can potentially improve therapeutic outcomes for individuals suffering from various conditions related to abnormal blood vessel growth.
Latest Patents
Frank Kuhnert holds a patent for "Methods of modulating angiogenesis." This invention provides methods for modulating angiogenesis in an individual by administering an agent that influences the expression or activity of Egfl7. Specifically, the patent describes how an agonist of Egfl7, including an Egfl7 polypeptide, can decrease angiogenesis. One embodiment of the invention emphasizes inhibiting pathological angiogenesis by enhancing the activity of Egfl7, which may be used alongside other anti-angiogenic agents.
Career Highlights
Frank Kuhnert is affiliated with Leland Stanford Junior University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential applications in treating diseases characterized by abnormal angiogenesis, such as cancer and diabetic retinopathy.
Collaborations
Frank has worked closely with Calvin Jay Kuo, contributing to advancements in their shared research interests. Their collaboration highlights the importance of teamwork in scientific innovation and the development of new therapeutic strategies.
Conclusion
Frank Kuhnert's innovative work in angiogenesis modulation represents a significant advancement in medical research. His patent and ongoing research efforts have the potential to lead to new treatments for conditions associated with abnormal blood vessel growth.